Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy
SUMMARY Objective: To evaluate the efficacy and safety of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy (HRT) in a randomized, double-blind, placebo-controlled trial. Methods: After a 6-week dietary lead-in period, 135 postmenopausal wom...
Saved in:
Published in | Current medical research and opinion Vol. 20; no. 10; pp. 1571 - 1578 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa UK Ltd
01.10.2004
Taylor & Francis Informa Healthcare |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!